ArticleClinical ophthalmology (Auckland, N.Z.)2025
Efficacy and Safety of Initial Outflow Reconstruction Using Ab Interno Microhook Trabeculotomy: A Retrospective Study in Secondary Glaucoma.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy and Safety of Initial Outflow Reconstruction Using Ab Interno Microhook Trabeculotomy: A Retrospective Study in Secondary Glaucoma [Response to Letter].Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Letter to the Editor: Efficacy and Safety of Initial Outflow Reconstruction Using Ab Interno Microhook Trabeculotomy: A Retrospective Study in Secondary Glaucoma [Letter].Clinical ophthalmology (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Establishing effective surgical interventions for secondary glaucoma (SG) remains a significant clinical challenge. We evaluated the efficacy and safety of initial outflow reconstruction using ab interno microhook trabeculotomy in patients with SG. Patients and Methods: This retrospective study included 39 eyes from 39 patients who underwent either standalone microhooktrabeculotomy or a combined triple procedure with cataract surgery in 2021. The cohort consisted of 18 eyes with exfoliation glaucoma, 15 with uveitic glaucoma, and 6 with steroid-induced glaucoma. Intraocular pressure (IOP) and glaucoma medication scores were recorded preoperatively and at 1, 3, 6, and 12 months postoperatively. Primary outcomes included the IOP reduction rate at 12 months, assessed using mixed effects analysis, and IOP control over time, analyzed via Kaplan-Meier survival curves (failure defined as < 20% IOP reduction or IOP > 21 mmHg on two consecutive visits). Risk factors for surgical failure were analyzed using Cox proportional hazards models. Furthermore, postoperative complications and the need for additional surgical interventions were evaluated. Results: The mean patient age was 65.1 ± 13.6 years, with 24 male participants. The mean preoperative IOP was 25.4 ± 9.3 mmHg, and the mean medication score was 4.2 ± 1.3 at 12 months postoperatively; these values significantly decreased to 14.9 mmHg and 3.1, respectively (P < 0.05). The mean IOP reduction rate at 12 months was 32.4%, and the Kaplan-Meier survival rate for IOP control was 60.3%. Cox hazard analysis indicated that older age and pseudophakia were associated with improved postoperative IOP control. The most common complication was anterior chamber hemorrhage (35.9%). Conclusion: Ab interno microhook trabeculotomy may represent an effective initial surgical strategy for lowering IOP and reducing the reliance on glaucoma medications in patients with SG, particularly among older individuals and those with pseudophakia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.